Matisse Pharmaceuticals B.V.
www.matisse-pharma.comMatisse Pharmaceuticals BV was founded in 2014 as a startup with the main objective to develop a therapeutic product for the treatment of sepsis. The company acquired a worldwide exclusive license on the heparin technology. Matisse Pharmaceuticals is based at the Brightlands Chemelot Campus in Geleen, The Netherlands.
Read more
Matisse Pharmaceuticals BV was founded in 2014 as a startup with the main objective to develop a therapeutic product for the treatment of sepsis. The company acquired a worldwide exclusive license on the heparin technology. Matisse Pharmaceuticals is based at the Brightlands Chemelot Campus in Geleen, The Netherlands.
Read more
Country
City (Headquarters)
Geleen
Industry
Employees
11-50
Founded
2014
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Business Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Owner , Innopact B.V.
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Matisse Pharmaceuticals B.V.
Free credits every month!
Matisse Pharmaceuticals B.V. FAQ
Geleen, Netherlands
Pharmaceutical Manufacturing
